logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (ii) All outpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium(1)3.93.82.72.31.76.82.53250
Bulgaria4.81.04.02.0840
Czech Republic2.30.71.50.87.03.66.02013
Denmark3.54.12.62.64.12.13912
Germany3.56.43.30.62.52.17.33.439870
Estonia:::::::::
Ireland2.75.22.71.61.25.50.24356
Greece5.95.02.03.46.02.02274
Spain(2)5.05.94.21.45.29.25.34.449101
France3.73.53.21.73.02.16.72.124807
Italy4.88.43.71.43.33.419.21.651609
Cyprus8.520.33.50.57.8532
Latvia:::::::::
Lithuania(3)4.31.32.31.913.67.54.65715
Luxembourg2.91.41.79.0275
Hungary(4)4.45.63.61.05.88.93.24108
Malta(5)4.77.32.21.08.1692
Netherlands(6)4.76.63.41.31.54.50.98722
Austria2.44.82.42.92.56.43438
Poland:::::::::
Portugal:::::::::
Romania(7)11.75.00.77.7495
Slovenia3.41.06.0686
Slovakia3.13.02.11.05.68.8759
Finland1.81.01.41.90.04.90.61197
Sweden1.83.31.81.34.04.04.04.31674
Uk2.73.11.81.63.21.63.32.0114450
Croatia4.83.47.31.78.78.06515
Turkey:::::::::
Norway:::::::::
Total3.55.12.31.43.32.85.52.63.8
Total base17997758351139205431461868685203762331290

Notes:

 : indicates data not available 

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Last available data refer to 2005 and to outpatient centres and low-threshold agencies (aggregated data). Brussels Capital Region is not covered. 

 (2) Data refer to 2006 and to outpatient and prison centres (aggregated data). 

 (3) For Hallucinogens 7 male cases have been reported.                     

 (4) Data refer to outpatient and inpatient treatment centres (aggregated data). For Hallucinogens 27 male cases have been reported. 

 (5) Last data available refer to 2006 and to outpatient, inpatient treatment centres, low-threshold agencies, units in prison and dual-diagnosis unit of psychiatric hospital (aggregated data). 

 (6) Data refer to outpatient and low-threshold agencies (aggregated data). 

 (7) For Cocaine 7 male cases have been reported. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009